Malats N - Search Results

1

Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Porta M, Malats N, Jariod M, Grimalt JO, Rifà J, Carrato A, Guarner L, Salas A, Santiago-Silva M, Corominas JM, Andreu M, Real FX. Porta M, et al. Among authors: malats n. Lancet. 1999 Dec 18-25;354(9196):2125-9. doi: 10.1016/s0140-6736(99)04232-4. Lancet. 1999. PMID: 10609819

2

Myelodysplastic syndromes and malignant solid tumors: analysis of 21 cases.

Sans-Sabrafen J, Buxó-Costa J, Woessner S, Florensa L, Besses C, Malats N, Porta M. Sans-Sabrafen J, et al. Among authors: malats n. Am J Hematol. 1992 Sep;41(1):1-4. doi: 10.1002/ajh.2830410102. Am J Hematol. 1992. PMID: 1503093

3

Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.

Porta M, Gallén M, Malats N, Planas J. Porta M, et al. Among authors: malats n. J Epidemiol Community Health. 1991 Sep;45(3):225-30. doi: 10.1136/jech.45.3.225. J Epidemiol Community Health. 1991. PMID: 1757766 Free PMC article.

4

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.

Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Malats N, et al. J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679. J Clin Oncol. 1995. PMID: 7602358

5

Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.

Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Porta M, et al. Among authors: malats n. J Clin Epidemiol. 1994 Sep;47(9):1069-79. doi: 10.1016/0895-4356(94)90123-6. J Clin Epidemiol. 1994. PMID: 7730910

6

Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.

Malats N, Porta M, Fernandez E, Real FX. Malats N, et al. J Natl Cancer Inst. 1994 Sep 7;86(17):1353-4; author reply 1355. doi: 10.1093/jnci/86.17.1353-a. J Natl Cancer Inst. 1994. PMID: 7914938 No abstract available.

7

Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators.

Maguire A, Porta M, Malats N, Gallén M, Piñol JL, Fernandez E. Maguire A, et al. Among authors: malats n. Eur J Cancer. 1994;30A(6):785-92. doi: 10.1016/0959-8049(94)90293-3. Eur J Cancer. 1994. PMID: 7917538

8

DDT and pancreatic cancer.

Malats N, Real FX, Porta M. Malats N, et al. J Natl Cancer Inst. 1993 Feb 17;85(4):328-9. doi: 10.1093/jnci/85.4.328. J Natl Cancer Inst. 1993. PMID: 8426376 No abstract available.

9

Disagreement between hospital medical records and a structured patient interview on the type and date of the first symptom in cancers of the digestive tract.

Malats N, Belloc J, Gallén M, Porta M. Malats N, et al. Rev Epidemiol Sante Publique. 1995 Dec;43(6):533-40. Rev Epidemiol Sante Publique. 1995. PMID: 8552851 Clinical Trial.

10

[Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract].

Gavaldà L, Porta M, Malats N, Piñol JL, Fernández E, Maguire A, Cortès I, Carrillo E, Marrugat M, Rifà J, et al. Gavaldà L, et al. Among authors: malats n. Gac Sanit. 1995 Nov-Dec;9(51):334-42. doi: 10.1016/s0213-9111(95)71258-4. Gac Sanit. 1995. PMID: 8666512 Free article. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters